Pharmaceuticals in South Africa
Pharmaceuticals in South Africa
SUMMARY
Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South African pharmaceuticals market had total revenues of $4,200.0m in 2019, representing a compound annual growth rate (CAGR) of 4.9% between 2015 and 2019.
- For pharmaceutical firms, the market presents a good opportunity, with growing disposable income, eclectic demographics, an aging population, and a diverse disease burden.
- The government is keen to keep increasing confidence in generics and open up the market to new players other than the market dominators, Aspen Pharmacare and Adcock Ingram.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Africa
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts
- What was the size of the South Africa pharmaceuticals market by value in 2019?
- What will be the size of the South Africa pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the South Africa pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in South Africa's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do leading players face?
8 COMPANY PROFILES
8.1. Adcock Ingram Holdings Ltd
8.2. Aspen Pharmacare Holdings Ltd
8.3. Novartis AG
8.4. Sanofi SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do leading players face?
8 COMPANY PROFILES
8.1. Adcock Ingram Holdings Ltd
8.2. Aspen Pharmacare Holdings Ltd
8.3. Novartis AG
8.4. Sanofi SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: South Africa pharmaceuticals market value: $ billion, 2015-19
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: South Africa pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: South Africa pharmaceuticals market share: % share, by value, 2019
Table 5: Adcock Ingram Holdings Ltd: key facts
Table 6: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 7: Adcock Ingram Holdings Ltd: Key Employees
Table 8: Aspen Pharmacare Holdings Ltd: key facts
Table 9: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 10: Aspen Pharmacare Holdings Ltd: Key Employees
Table 11: Novartis AG: key facts
Table 12: Novartis AG: Annual Financial Ratios
Table 13: Novartis AG: Annual Financial Ratios (Continued)
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: Annual Financial Ratios
Table 18: Sanofi SA: Key Employees
Table 19: Sanofi SA: Key Employees Continued
Table 20: South Africa size of population (million), 2015-19
Table 21: South Africa gdp (constant 2005 prices, $ billion), 2015-19
Table 22: South Africa gdp (current prices, $ billion), 2015-19
Table 23: South Africa inflation, 2015-19
Table 24: South Africa consumer price index (absolute), 2015-19
Table 25: South Africa exchange rate, 2015-19
Table 1: South Africa pharmaceuticals market value: $ billion, 2015-19
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: South Africa pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: South Africa pharmaceuticals market share: % share, by value, 2019
Table 5: Adcock Ingram Holdings Ltd: key facts
Table 6: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 7: Adcock Ingram Holdings Ltd: Key Employees
Table 8: Aspen Pharmacare Holdings Ltd: key facts
Table 9: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 10: Aspen Pharmacare Holdings Ltd: Key Employees
Table 11: Novartis AG: key facts
Table 12: Novartis AG: Annual Financial Ratios
Table 13: Novartis AG: Annual Financial Ratios (Continued)
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: Annual Financial Ratios
Table 18: Sanofi SA: Key Employees
Table 19: Sanofi SA: Key Employees Continued
Table 20: South Africa size of population (million), 2015-19
Table 21: South Africa gdp (constant 2005 prices, $ billion), 2015-19
Table 22: South Africa gdp (current prices, $ billion), 2015-19
Table 23: South Africa inflation, 2015-19
Table 24: South Africa consumer price index (absolute), 2015-19
Table 25: South Africa exchange rate, 2015-19
LIST OF FIGURES
Figure 1: South Africa pharmaceuticals market value: $ billion, 2015-19
Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: South Africa pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in South Africa, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Africa, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Africa, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2019
Figure 10: South Africa pharmaceuticals market share: % share, by value, 2019
Figure 1: South Africa pharmaceuticals market value: $ billion, 2015-19
Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: South Africa pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in South Africa, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Africa, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Africa, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2019
Figure 10: South Africa pharmaceuticals market share: % share, by value, 2019
